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Plant biologists have recognized the potential in using small molecules identified from 
chemical libraries to provide insights into biological questions relevant to plants. However, 
the classical genetics mindset still predominant among plant scientists should evolve to 
embrace cross-disciplinary chemical genetic projects that will benefit future plant research. 
 
Historically, chemistry and plants have been tightly linked because plants, as a source of highly 
diverse natural products, have inspired synthetic chemists and drug developers. Furthermore, the 
discovery of phytohormones and their receptor-mediated signaling pathways have piqued the 
interest of many plant biologists to search chemical space to identify functionally similar small 
bioactive compounds. Over the last two decades, the focus has shifted towards more targeted 
classical genetics research wherein plant biologists have rationally perturbed biological 
responses to address fundamental questions1. 
 The contribution of classical genetics towards the advancement of plant science is 
irrefutable, but the role of chemical genetics needs to be seriously considered as well1,2. Despite 
being a relatively young discipline, plant chemical genetics has already proven its potential to 
bridge a number of genotype-to-phenotype gaps observed in plant classical genetics1,2. Chemical 
genetics, which is a part of the much broader chemical biology theme, deals with the application 
of small molecules that can selectively modulate the function of a protein or of members of a 
protein family, resembling phenotypically (a) genetic mutation(s) of the protein-encoding gene3. 
When compared to the vast scientific literature in the drug discovery field, the scope of plant 
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chemical genetics research is still relatively small but has begun to increase in recent years. At 
this stage, plant biologists need to consider the balance between traditional genetics and chemical 
genetics as approaches to probe mechanisms in plant biology (Fig. 1). 
 Arabidopsis thaliana (L.) Heynh. (Arabidopsis) has emerged as a leading model system for 
plant genetics studies, and offers many advantages for chemical genetics, including a well-
annotated genome, ease of growth in multi-well plates and on various media, and availability of 
reporter systems, amongst others. Because classical genetics has difficulty overcoming issues of 
gene redundancy, lethality, and pleiotropy, small molecules offer a promising alternative, along 
with the added feature that chemical probes may be used to control function in a precise time 
frame or in a reversible or dose-dependent manner2. 
 The identification of abscisic acid (ABA) receptors of Arabidopsis represents a 
foundational contribution of plant chemical genetics wherein a phenotype-based (i.e., forward 
chemical genetics) screen resulted in the discovery of the small molecule pyrabactin4. When 
employed as a probe, pyrabactin was found to act as a selective agonist for the ABA receptor 
PYR1. Since that time, many laboratories have adopted chemical genetics screens to study 
endomembrane trafficking5, phytohormone signaling6-10, pathogen defense11, as well as plant cell 
wall modifications12,13, amongst several others. These examples provide ample demonstration of 
the complementarity of plant chemical genetics to traditional plant biology approaches.  
 Despite the growing interest in using chemical genetics in plant research, the number of 
plant biology labs applying chemical genetics remains low and still faces many technological 
hurdles. Here we explore these challenges and discuss how plant chemical genetics may be 
advanced by adopting chemical biology approaches that have matured from their use in other 
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biological systems and by fostering greater interaction and collaboration among plant and 
chemical biologists.  
 
Existing challenges 
 An immediate challenge for budding plant chemical geneticists is selecting the right 
chemical library for a plant-based chemical screen. Conventional libraries that are frequently 
used in chemical screens include fragment-based libraries, focused libraries, approved drug 
collections, and unbiased collections. Many chemical libraries, such as ChemBridge DIVERSet, 
Analyticon Discovery, and Prestwick Library etc., are available commercially1. Compounds are 
generally dissolved in a suitable solvent, such as dimethyl sulfoxide and are supplied in 96-well 
or 384-well formats. The libraries are easily accessible and can be utilized extensively by plant 
biologists1, but most of them are inclined towards targeted screens used in mammalian cell 
culture assays and are designed according to mammalian cells absorption, distribution, 
metabolism, and excretion (ADME) criteria, and to adhere to the Lipinski’s Rule of Five1. Thus, 
such libraries might be less suited to yield bioactive compounds for intact plants. Using high 
concentrations for plant screens can overcome some uptake issues, but, at the same time, may 
impart unwanted toxic or non-specific effects in plants. Besides the suitability of the libraries for 
plants, a rather different obstacle lies in the high cost of these chemical collections which might 
limit their use by individual labs. 
 The design and choice of chemical screening phenotypes, access to specialized high-
throughput screening facilities and proper automation for rapid analysis are some of the key 
impediments that require attention. Initially, the discovery of small molecules in plants was 
mainly centered on qualitative forward chemical genetic screens which scored phenotypes 
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resembling known hormonal treatments or existing mutants such as hypocotyl and root lengths, 
lateral root numbers, venation patterns, or endomembrane trafficking perturbations1. While such 
chemical screens delivered interesting and potentially useful candidate hits, the resulting target 
validation revealed that the observed phenotypes were often due to alterations in diverse 
biological pathways, beyond what was predicted, making the effects less specific1. Therefore, 
development of well-designed and pathway-focused scoring and screening systems using in vivo 
selective marker and gene-reporter assays need to be employed to assess whether a particular 
signaling pathway is altered. The discovery of jarin-1 as a jasmonate signaling inhibitor was a 
result of such a strategy (Fig. 2a)9. The availability of jasmonate-responsive reporters facilitated 
an easy and focused phenotypic screening followed by validation and target identification based 
on the plethora of available knowledge regarding jasmonate signaling components and their 
biological activities. Employing such pathway-focused screens would assist in the elimination of 
compounds with broader and non-specific effects.  
 Plant researchers also face the challenge that they currently have limited access to 
traditional ‘medicinal chemistry’ approaches commonly used to probe the mechanism of small 
molecule action. As an example, after identifying a hit from a screen, an inexperienced plant 
chemical geneticist may proceed towards target identification with a non-optimized hit 
compound. This overlooks the important structure-activity relationship analysis and compound 
hit optimization steps, including potency and selectivity assays that are normally done in 
pharmaceutical research. As a result, these non-optimized hit compounds have low target 
affinities or potential cellular uptake liabilities, which hinder their use in the downstream target-
identification process and limit their applicability as chemical probes in plants. There are many 
potential reasons for this jump to target identification stages. Firstly, a typical plant chemical 
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genetic project from conceptualization to target identification and designing new effective 
analogs, which if not available from commercial sources, is time-consuming. In addition, the 
costs of medicinal chemistry involved in creating such analogs can run high which may 
demotivate some project leaders working on tight budgets. Finally, the lack of suitable chemical 
infrastructure in plant research centers can be a major impediment. 
While the above-mentioned factors stand in the way of plant biologists adopting a chemical 
genetic mindset in their research, there are promising signs of progress. 
 
Changing the mindset 
 For a plant biologist, the ability to grasp concepts of other scientific disciplines such as 
chemistry that are needed for expertise in chemical genetic approaches may be uncomfortable at 
first. However, the next generation of plant biologists needs to broaden their horizons, and this 
begins with early training. Young plant scientists should be encouraged and supported to attend 
training programs focused at the intersection between chemistry and biology. The European 
Molecular Biology Organization (EMBO) chemical biology training programs are notable in this 
regard. Similarly, early-stage plant scientists interested in chemical genetics should participate 
and attend cross-disciplinary chemical biology conferences to interact with a diverse group of 
participants from chemistry departments and pharmaceutical companies to foster collaborations 
and learn about new and emerging chemical tools. In this regard, the development of focused 
plant chemical biology conferences or symposiums will encourage plant chemical geneticists to 
present their research work, learn from experts, and foster collaboration with industrial partners. 
Furthermore, plant biologists should routinely enter into discussions and collaborations with 
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chemists or biophysicists who have a shared goal of advancing mechanistic understanding in 
plant science.  
 Changing our mindset on how to design and implement chemical screens is another route 
to consider. Recently, there has been a growing trend of switching from phenotypic chemical 
genetic screens towards target-based or reverse chemical genetic approaches (Fig. 2b). For 
example, NPD12704 was recently identified in a target-based screen as the first peptide-hormone 
signaling inhibitor in Arabidopsis14. In this work, a receptor kinase of choice, BAM1, was 
immobilized on beads and subjected to a chemical library to identify compounds that interfered 
with the binding of BAM1’s peptide ligand, CLE9. In this way, only receptor-specific 
compounds were identified, thereby avoiding off-targets. Shifting from a phenotypic to target-
based approach can be further complemented by the advancements in NMR-based screening, 
structural biology, in silico analyses, and three-dimensional structural modeling of proteins. 
Consequently, we are now in a position to apply this knowledge to modify either or both 
endogenous ligands and their protein receptors to perform targeted chemical genetics approaches 
(Fig. 2c, d)15-17 For example, modification of the endogenous jasmonoyl-isoleucine ligand has 
been shown to selectively activate the JAZ9-EIN3/EIL1-ORA59 signaling branch of jasmonate 
signaling15. Similarly, a modified fluorogenic strigolactone agonist, Yoshimulactone Green, has 
proven useful to study functions of the Arabidopsis D14-type strigolactone receptors and to 
dissect the signal perception mechanism of strigolactone receptors in the parasitic plant Striga16. 
Also, in a slightly different approach based on the crystal structure of the TIR1-IAA-AUX/IAA 
complex of auxin signaling, an orthogonal small molecule-based system has been designed to 
produce a modified “convex auxin” (cvxIAA) that binds only to an altered receptor (ccvTIR1). 
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This system eliminates interference with endogenous IAA-TIR1 signaling17 and bypasses genetic 
redundancy and feedback regulations.  
 In light of the success stories outlined above, plant biologists should feel motivated to 
utilize the structural information available for their proteins of interest and collaborate with X-
ray crystallographers and chemoinformatics experts to employ in silico methods as a general way 
of identifying novel binding sites in their protein of interest as well as within the whole plant 
proteome (Fig. 3). While structural modeling provides an initial start, detailed cellular and target 
identification studies are still needed to confirm and validate small molecule-target interactions, 
so plant biologists also need to strengthen their connections with chemical biologists.  
 
Tackling target identification 
Classical genetics has greatly enabled target identification for small-molecule compounds in 
plants. The most common approach involves analyzing the biological activity of a compound 
across a mutagenized seed population to link activity perturbations to potential molecular targets 
using genome sequencing and mapping1,2,18. However, classical genetics as a means of target 
identification is limited in cases where the target is an essential gene, which may cause 
embryonic lethality when mutated. As a result, new approaches are needed to advance target 
identification in plants. 
While chemical proteomics has proven to be a powerful tool in drug discovery research18, 
only a few labs have successfully utilized it in plants19-22 as such approaches generally require 
extensive chemical probe synthesis. In such scenarios, plant biologists should actively 
collaborate with organic chemists to design improved analogs with enhanced bioactivity or 
affinity probes derived from the bioactive compound to allow target identification methods. (Fig. 
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3). In addition, they should also develop inactive structural analogs of their chemical probes to 
use as negative control compounds in their experiments. 
 Plant biologists could also consider certain biochemical methods, such as the drug affinity 
responsive target stability (DARTS) and cellular thermal shift assay (CETSA), in which 
compound modification is not required for target identification and validation18. For instance, the 
small molecule ES9-17, a clathrin-mediated endocytosis inhibitor, was recently validated to bind 
to its target, clathrin heavy chain, via DARTS and CETSA21. An inherent advantage of using 
these methods lies in their complementation with advanced mass spectrometry and 
transcriptomic methods to study the impact of a small molecule at a global proteome or genome 
level (Fig. 3). Given that such core facilities are generally accessible to plant biologists, they 
should not feel confident in undertaking chemical genetics projects from this perspective. It is 
important to realize that one of the main advantages of studying the mode-of-action and 
identifying protein targets of bioactive compounds is the high probability of detecting proteins 
with unannotated function as well as uncovering novel functions of a protein in additional 
signaling pathways. 
 
Bridging the gaps  
In the “Existing challenges” section, we discussed issues with accessing chemical libraries for 
plant-based screens. One way to tackle this problem is the establishment of inter-laboratory 
screening “core” facilities with access to useful chemical libraries for all the participating 
laboratories. Many research institutes may already possess annotated compound collections that 
can be easily accessed for possible chemical biology projects, often for external investigators. As 
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these chemical libraries may have been successful in screenings of other model organisms, the 
potential for an abundant amount of cross-disciplinary knowledge might prove worthwhile.  
 Current chemical libraries designed for mammalian screening may not be sufficient, given 
the presence of a cell wall in plants, which might affect compound permeation. Arabidopsis 
seedlings can easily fit in 24 to 96 well plates1,2 and can be grown relatively inexpensively in 
either solid or liquid growth media to screen compounds. To this end, the use of liquid media, 
which in addition to providing high compatibility with automation can also assist in answering 
the key concern of compound bioavailability. Most likely, only those compounds that can 
permeate the cell-wall barrier shall be able to modulate a biological response in the cell, although 
responses initiated at the cell-wall level can also be interesting.  
 Another approach could be collaborating with chemical biologists to create new chemical 
libraries suited for screening in plants that may enhance success and address the shortcomings of 
current libraries. Thankfully, for aspiring plant chemical geneticists, certain plant-focused 
compound collections are available: LATCA (Library of AcTive Compounds on Arabidopsis) 
and Plasma Membrane Recycling Set A and Set B (PMRA/B), which were assembled from 
different libraries and have been successfully tested on plants1. Hence, plant biologists who 
utilize such libraries instead of completely unannotated chemical libraries can be more assured of 
discovering compounds with a biological effect and some initial knowledge about their mode-of-
action.  
 Entering into industrial collaborations is a unique way to access chemical space that may 
not be widely available (Fig. 3). The pharmaceutical and agrochemical companies are excellent 
sources of compound collections because they routinely synthesize and test new chemical 
scaffolds. Over the years, detection of compounds with a new mode-of-action, searching for new 
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druggable targets, and overcoming small-molecule resistance have become key challenges for 
the industry. Not surprisingly, many collaborations between pharmaceutical companies and 
academia have been implemented after notable successes have provided tremendous benefits for 
both communities23. For the plant world, a few promising initiatives such as the AGRI-net 
chemical biology society and EU-OPENSCREEN have started to bring together industrial and 
academic communities together to develop novel research tools for plant sciences24. The 
possibility that teaming up with an industrial partner on a chemical genetics project may convert 
an idea into a tangible marketable product should push plant scientists to seek industrial 
collaborations. In such cases, early negotiations around issues of patent protection and 
intellectual property would ensure fruitful collaborations.  
 
Final perspectives 
Chemical genetics has been useful in addressing diverse biological questions but the potential to 
apply this approach towards emerging fields in plant biology remains tantalizing. The 
implementation of recent advances in chemical biology such as bio-orthogonal chemistry17, 
fluorescently labeled peptide ligands14 and optogenetic probes25 have a strong potential to 
mitigate certain limitations of classical plant genetics.  
 We propose a holistic approach toward increasing awareness about chemical genetics 
within the plant science world. Visibility of plant chemical genetics needs to be increased at 
international plant biology conferences and in scientific journals. At the same time, we need to 
provide appropriate training to early career plant biologists in areas such as chemical screenings, 
chemical probe development, application, and target identification.  
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 In addition to instrument automation, improved microscopy, and plant-based chemical 
library accessibility, plant biologists need more venues to discuss their findings. This could be 
facilitated through annual plant chemical genetics workshops or online platforms where expert 
plant chemical geneticists share knowledge and resources to help early-stage researchers in their 
chemical genetics campaigns. We hope that plant biologists will make a concerted effort to work 
more closely with chemical biologists and adopt a chemical genetics mindset to advance the 




1. Dejonghe, W. & Russinova, E. Plant Physiol. 174, 5-20 (2017). 
2. Hicks, G. R. & Raikhel, N. V. Front. Plant Sci. 5, 455 (2014). 
3. Bucci, M., Goodman, C. & Sheppard, T. L. Nat. Chem. Biol. 6, 847-854 (2010). 
4. Park, S.-Y. et al. Science 324, 1068-1071 (2009). 
5. Drakakaki, G. et al. Proc. Natl. Acad. Sci. USA 108, 17850-17855 (2011). 
6. Halder, V. et al. Sci. Rep. 9, 11196 (2019).  
7. He, W. et al. Plant Cell 23, 3944-3960 (2011). 
8. Tsuchiya, Y. et al. Nat. Chem. Biol. 6, 741-749 (2010). 
9. Meesters, C. et al. Nat. Chem. Biol. 10, 830-836 (2014). 
10. De Rybel, B. et al. Chem. Biol. 16, 594-604 (2009). 
11. Bektas, Y. & Eulgem, T. Front. Plant Sci. 5, 804 (2015). 
12. Brabham, C. & DeBolt, S. Front. Plant Sci. 3, 309 (2013). 
13. Yoneda, A. et al. Plant Cell Physiol. 48, 1393-1403 (2007). 
14. Shinohara, H. et al. Commun. Biol. 2, 61 (2019). 
15. Takaoka, Y. et al. Nat. Commun. 9, 3654 (2018). 
16. Tsuchiya, Y. et al. Science 349, 864-868 (2015). 
17. Uchida, N. et al. Nat. Chem. Biol. 14, 299-305 (2018). 
18. Dejonghe, W. & Russinova, E. Front. Plant Sci. 5, 352 (2014). 
19. Zhang, C. et al. Proc. Natl. Acad. Sci. USA 113(1):E41-50 (2016). 
20. Mishev, K. et al. Plant Cell 30, 2573-2593 (2018). 
21. Dejonghe, W. et al. Nat. Chem. Biol. 15, 641-649 (2019).  
22. Uehara, T.N. et al. Proc. Natl. Acad. Sci. USA 116(23):11528-11536 (2019).  
23. Mallapaty S. Nature 552, S5 (2017). 
13 
 
24. Meiners, T., Stechmann, B. & Frank, R. J. Chem. Biol. 7, 113-118 (2014). 
25. Papanatsiou, M. et al. Science 363(6434):1456-1459 (2019).  
 
Affiliations 
Vivek Halder and Eugenia Russinova are in the Department of Plant Biotechnology and 
Bioinformatics, Ghent University, 9052 Ghent, Belgium and the Center for Plant Systems 
Biology, VIB, 9052 Ghent, Belgium. 




We thank Natasha Raikhel, Glenn R. Hicks, Tom Beeckman, Markus Kaiser, Dominique 
Audenaert, Wim Dejonghe and Kiril Mishev for critical reading and valuable suggestions, and 
Martine De Cock for help in preparing the manuscript. This work was supported by the Research 
Foundation-Flanders (project 3G009018 to E.R.). 
 
Competing financial interests 





Figure 1: The balance between classical genetics and chemical genetics for probing mechanisms 
in plant biology. Classical genetics (left side), which involves mutagenizing plants and mapping 
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the relevant genes that cause the mutant phenotype and has historically served as the primary 
study method in basic plant research. Chemical genetics (right side) involves the application of a 
small molecule that resembles genetic mutations of the protein-encoding gene phenotypically. 
 
Figure 2: Conventional and current trends in plant chemical genetics (a) Forward chemical 
genetics, illustrated by jarin-1 that targets the JAR1 enzyme in the JA-signaling pathway, 
involves a qualitative or quantitative phenotypic screening followed by compound 
characterization and protein target identification (b) Reverse chemical genetics, exemplified by 
NPD12704 that targets the Arabidopsis receptor kinase BAM1 and interferes with the binding of 
its cognate peptide ligand CLE9, is a relatively recent trend in plant chemical genetics which 
involves screening of a chemical library against a purified protein of interest. (c, d) Another 
variant of reverse chemical genetics involves modifying endogenous ligands such as the 
modified strigolactone, yoshimulactone green, which binds to strigolactone D-14 receptor; or the 
modified jasmonate, jasmonoyl-isoleucine, which can selectively activate JAZ9-EIN3/EIL1-
ORA59 signaling. A slightly different approach involves modification of both endogenous ligand 
and its receptor as seen in the case of modified convex auxin (cvxIAA) that selectively binds to 
its modified concave receptor (cvvTIR1).  
 
Figure 3: Plant chemical genetics will benefit from cross-disciplinary approaches. To broaden 
the scope of plant chemical genetics, plant biologists need to harness the advances in the fields of 
chemistry, proteomics, transcriptomics, computational biology, crystallography, and collaborate 
with academic and industrial partners. 
 
